William Blair Starts aTyr Pharma (LIFE) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
Go back to William Blair Starts aTyr Pharma (LIFE) at Outperform
June 1, 2015 8:04 AM EDT
Citi initiated coverage on aTyr Pharma (NASDAQ: LIFE) with a Buy rating and a price target of $32.00.
For an analyst ratings summary and ratings history on aTyr Pharma click here. For more ratings news on aTyr Pharma click here.
Shares of aTyr Pharma closed at $22.89 yesterday.
...
More
June 1, 2015 6:57 AM EDT
JPMorgan initiated coverage on aTyr Pharma (NASDAQ: LIFE) with an Overweight rating and a price target of $42.00.
For an analyst ratings summary and ratings history on Life Technologies click here. For more ratings news on Life Technologies click here.
Shares of Life Technologies closed at $22.89 yesterday.
...
More
June 1, 2015 6:34 AM EDT
(Updated - June 1, 2015 7:03 AM EDT)
BMO Capital initiates coverage on aTyr Pharma (NASDAQ: LIFE) with a Outperform rating and a price target of $42.00.
Analyst Jim Birchenough commented, "Our favorable rating and outlook is supported by the company's identification of, and proprietary dominance in, the area of Physiocrine... More
